Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

[Expression of HER-2 and leptin in gastric cancer and their clinical significance].

Geng YT, Qiu JR, Wang R, Su YT, Shu YQ, Yin YM.

Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):764-9. Chinese.

PMID:
22335909
2.

Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients.

Geng Y, Wang J, Wang R, Wang K, Xu Y, Song G, Wu C, Yin Y.

Biomed Pharmacother. 2012 Sep;66(6):419-24. doi: 10.1016/j.biopha.2012.03.002. Epub 2012 Mar 27.

PMID:
22883999
3.

Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.

Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K.

Ann Surg Oncol. 2007 Oct;14(10):2738-47. Epub 2007 Aug 9.

PMID:
17687613
4.
5.

Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer.

Zhao X, Huang K, Zhu Z, Chen S, Hu R.

J Gastroenterol Hepatol. 2007 Aug;22(8):1317-21. Epub 2007 Jun 7.

PMID:
17559372
6.
7.

[Relationship between Ets-1 expression and angiogenesis, clinicopathological features and survival of patients with gastric carcinoma].

Ren TW, Zhou YN, Wu J, Zhang ZY, Hao TJ, Wang JX, Zou SJ, Chen ZF, Huang SS, Zhang LH, Zhao Y.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):674-8. Chinese.

PMID:
20021863
8.

Significant prognostic factors in patients with early gastric cancer.

Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H.

Int Surg. 2000 Oct-Dec;85(4):286-90.

PMID:
11589593
9.

Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.

Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ.

Ann Surg Oncol. 2009 Feb;16(2):297-303. doi: 10.1245/s10434-008-0221-7. Epub 2008 Dec 3.

PMID:
19050975
10.

[Clinical analysis of the current treatment status of gastric cancer in 636 patients].

Zhuang QX, Xu JM, Lin L, Ge FJ, Liu LJ, Wang Y, Zhao CH.

Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):316-20. doi: 10.3760/cma.j.issn.0253-3766.2012.04.017. Chinese.

PMID:
22781048
11.

[Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].

Su XJ, Tang ZF, Li Q, Li HL, Li LL, Liu M, Zhou YN.

Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):276-9. Chinese.

PMID:
21575498
12.

[Association of HER-2/neu expression with prognosis of gastric cancer].

Chen B, Luo RC, Cui F, Qian XY.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Mar;26(3):344-7. Chinese.

14.

Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.

Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M.

J Surg Oncol. 2007 Feb 1;95(2):123-8.

PMID:
17262742
15.

The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.

Huang C, Huang R, Chang W, Jiang T, Huang K, Cao J, Sun X, Qiu Z.

Neoplasma. 2012;59(1):52-61. doi: 10.4149/neo_2012_007.

PMID:
22082308
16.

Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.

Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y.

Hepatogastroenterology. 2009 May-Jun;56(91-92):908-13.

PMID:
19621727
17.

[HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].

Wang Y, Xu JM, Liu JZ, Lin L, Ge FJ, Li SS, Liu LJ, Zhao CH.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):671-5. Chinese.

PMID:
22340047
18.

Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer.

Geng Y, Chen X, Qiu J, Zhou Y, Wang J, Liu L, Shao Y, Yin Y.

Int J Clin Oncol. 2014 Apr;19(2):303-11. doi: 10.1007/s10147-013-0542-9. Epub 2013 May 10.

PMID:
23660785
19.

Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.

Ismail HM, Moneer M, El-Baradie M, Khorshid O, Touny A.

J Egypt Natl Canc Inst. 2007 Jun;19(2):147-57.

20.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329

Supplemental Content

Support Center